SMAD2 and non-small cell lung carcinoma: Hang et al. showed that m6A RNA methylation maintains RMRP stability through the TGFBR1/SMAD2/SMAD3 pathway, which ultimately leads to the advancement and progression of non-small cell lung cancer [38].